110 related articles for article (PubMed ID: 24727229)
41. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.
Paulson SK; Zhang JY; Breau AP; Hribar JD; Liu NW; Jessen SM; Lawal YM; Cogburn JN; Gresk CJ; Markos CS; Maziasz TJ; Schoenhard GL; Burton EG
Drug Metab Dispos; 2000 May; 28(5):514-21. PubMed ID: 10772629
[TBL] [Abstract][Full Text] [Related]
42. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
43. Mechanism of adrenocortical toxicity induced by quinocetone and its bidesoxy-quinocetone metabolite in porcine adrenocortical cells in vitro.
Wang X; Wan D; Ihsan A; Liu Q; Cheng G; Li J; Liu Z; Yuan Z
Food Chem Toxicol; 2015 Oct; 84():115-24. PubMed ID: 26296292
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
[TBL] [Abstract][Full Text] [Related]
45. Disposition and metabolism of N,N-dimethylacetoacetamide in male F344 and Wistar-Han rats and female B6C3F1 mice.
Fennell T; Watson S; Snyder R; Jeffcoat R; Waidyanatha S
Xenobiotica; 2011 Nov; 41(11):1013-20. PubMed ID: 21819270
[TBL] [Abstract][Full Text] [Related]
46. Metabolism, disposition, excretion, and pharmacokinetics of levormeloxifene, a selective estrogen receptor modulator, in the rat.
Mountfield RJ; Kiehr B; John BA
Drug Metab Dispos; 2000 May; 28(5):503-13. PubMed ID: 10772628
[TBL] [Abstract][Full Text] [Related]
47. Absorption, tissue distribution, excretion, and metabolism of clothianidin in rats.
Yokota T; Mikata K; Nagasaki H; Ohta K
J Agric Food Chem; 2003 Nov; 51(24):7066-72. PubMed ID: 14611173
[TBL] [Abstract][Full Text] [Related]
48. Comparative disposition of 2,3-epoxy-1-propanol (glycidol) in rats following oral and intravenous administration.
Nomeir AA; Silveira DM; Ferrala NF; Markham PM; McComish MF; Ghanayem BI; Chadwick M
J Toxicol Environ Health; 1995 Feb; 44(2):203-17. PubMed ID: 7853422
[TBL] [Abstract][Full Text] [Related]
49. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
50. Absorption, distribution, metabolism, and elimination of 8-2 fluorotelomer alcohol in the rat.
Fasano WJ; Carpenter SC; Gannon SA; Snow TA; Stadler JC; Kennedy GL; Buck RC; Korzeniowski SH; Hinderliter PM; Kemper RA
Toxicol Sci; 2006 Jun; 91(2):341-55. PubMed ID: 16543293
[TBL] [Abstract][Full Text] [Related]
51. Disposition of low doses of 14C-bisphenol A in male, female, pregnant, fetal, and neonatal rats.
Kurebayashi H; Nagatsuka S; Nemoto H; Noguchi H; Ohno Y
Arch Toxicol; 2005 May; 79(5):243-52. PubMed ID: 15902421
[TBL] [Abstract][Full Text] [Related]
52. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
Prakash C; Kamel A; Anderson W; Howard H
Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
[TBL] [Abstract][Full Text] [Related]
53. Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to rats.
Wasan KM; Peteherych KD; Najafi S; Zamfir C; Pritchard PH
J Pharm Pharm Sci; 2001; 4(3):207-16. PubMed ID: 11737986
[TBL] [Abstract][Full Text] [Related]
54. The disposition and metabolism of methyl acrylate in male Wistar albino rats.
Sapota A
Pol J Occup Med Environ Health; 1993; 6(2):185-93. PubMed ID: 8219909
[TBL] [Abstract][Full Text] [Related]
55. Disposition of o-benzyl-p-chlorophenol in male rats.
Kao LR; Birnbaum LS
J Toxicol Environ Health; 1986; 18(3):441-58. PubMed ID: 3712501
[TBL] [Abstract][Full Text] [Related]
56. The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
Vickers S; Duncan CA; Arison BH; Davies RO; Ferguson R; Zacchei AG
Drug Metab Dispos; 1980; 8(3):163-7. PubMed ID: 6104580
[TBL] [Abstract][Full Text] [Related]
57. Plasma pharmacokinetics of quinocetone in ducks after oral and intravenous administration.
Qiu M; Hao Z; Zhang R; Cui L; Wang C; Qu S; Yuan S; Bai Y
J Vet Pharmacol Ther; 2018 Feb; 41(1):142-147. PubMed ID: 28730638
[TBL] [Abstract][Full Text] [Related]
58. Disposition of 2-mercaptobenzothiazole and 2-mercaptobenzothiazole disulfide in rats dosed intravenously, orally, and topically and in guinea pigs dosed topically.
el Dareer SM; Kalin JR; Tillery KF; Hill DL; Barnett JW
J Toxicol Environ Health; 1989; 27(1):65-84. PubMed ID: 2724369
[TBL] [Abstract][Full Text] [Related]
59. Disposition and metabolism of [2-14C]epichlorohydrin after oral administration to rats.
Gingell R; Mitschke HR; Dzidic I; Beatty PW; Sawin VL; Page AC
Drug Metab Dispos; 1985; 13(3):333-41. PubMed ID: 2861993
[TBL] [Abstract][Full Text] [Related]
60. Metabolism and disposition of vatalanib (PTK787/ZK-222584) in cancer patients.
Jost LM; Gschwind HP; Jalava T; Wang Y; Guenther C; Souppart C; Rottmann A; Denner K; Waldmeier F; Gross G; Masson E; Laurent D
Drug Metab Dispos; 2006 Nov; 34(11):1817-28. PubMed ID: 16882767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
